Sirona Biochem Corp. Stock Other OTC
Equities
SRBCF
CA82967M1005
Biotechnology & Medical Research
Sales 2022 | 672K 492K | Sales 2023 | 34.78K 25.48K | Capitalization | 21.44M 15.7M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.2M | Net income 2023 | -2M -1.47M | EV / Sales 2022 | 48.8 x |
Net Debt 2022 | 48.04K 35.19K | Net Debt 2023 | 1.61M 1.18M | EV / Sales 2023 | 663 x |
P/E ratio 2022 |
-8.81
x | P/E ratio 2023 |
-8.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.41% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 | |
Chief Tech/Sci/R&D Officer | - | 11-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Alex Marazzi
BRD | Director/Board Member | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 |
1st Jan change | Capi. | |
---|---|---|
+50.61% | 63.85B | |
-2.34% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.63% | 26.52B | |
-21.60% | 18.69B | |
+3.01% | 12.73B | |
+22.00% | 12.11B | |
+27.97% | 12.07B |